Arsenic trioxide decreases the amount and inhibits the function of regulatory T cells, which may contribute to its efficacy in the treatment of acute promyelocytic leukemia

Xu, W; Li, XX; Quan, LN; Yao, JY; Mu, GN; Guo, JJ; Wang, YT

Xu, W (reprint author), Harbin Med Univ, Dept Immunol, 157 Baojian Rd, Harbin 150086, Heilongjiang, Peoples R China.

LEUKEMIA & LYMPHOMA, 2018; 59 (3): 650

Abstract

Arsenic trioxide (ATO) exhibits substantial clinical efficacy in the treatment of acute promyelocytic leukemia (APL). Here, we investigated whether AT......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索